Ahmed Salem's profile photo

Ahmed Salem

Featured in: Favicon medium.com Favicon dailymail.co.uk Favicon nature.com Favicon reuters.com Favicon independent.co.uk Favicon wiley.com Favicon yahoo.com (+1) Favicon plos.org Favicon apnews.com Favicon frontiersin.org

Articles

  • Jan 20, 2025 | dev.to | Ahmed Salem

    In this guide, we’ll explore how to assign a Fully Qualified Domain Name (FQDN) to an EC2 instance running a web server using AWS Route 53. This process includes deploying CloudFormation templates, configuring Route 53, and ensuring the FQDN resolves to the EC2 instance’s public IP. OverviewWe aim to assign a domain name to a web server hosted on an EC2 instance. Instead of accessing the server using a public IP, we’ll use a friendly FQDN (e.g., www.cmcloudlab1589.info).

  • Jul 12, 2024 | dev.to | Ahmed Salem

    In this tutorial, we’ll explore how to use AWS Lambda Layers to organize and reuse code across multiple AWS Lambda functions. Specifically, we’ll move DynamoDB queries to a separate Lambda Layer and integrate it with a Serverless API. This approach enhances maintainability and promotes code reuse, making your serverless applications more scalable and efficient.

  • May 22, 2024 | ascpt.onlinelibrary.wiley.com | Ahmed Salem

    BACKGROUND AND MECHANISM OF ACTION Overexpression of the anti-apoptotic protein BCL-2 allows cancer cells to evade apoptosis by sequestering pro-apoptotic proteins. Venetoclax (ABT-199, GDC-0199) is a selective, highly potent, first-in-class orally bioavailable, BH3 mimetic inhibitor of BCL-2. As shown in Figure 1, venetoclax binds selectively to BCL-2 freeing pro-apoptotic proteins that initiate programmed cell death or apoptosis.

  • Apr 24, 2024 | nature.com | Meenakshi Hegde |Shoba Navai |Khaled Sanber |Ahmed Gad |Riyue Bao |Ahmed Salem | +5 more

    AbstractIn this prospective, interventional phase 1 study for individuals with advanced sarcoma, we infused autologous HER2-specific chimeric antigen receptor T cells (HER2 CAR T cells) after lymphodepletion with fludarabine (Flu) ± cyclophosphamide (Cy): 1 × 108 T cells per m2 after Flu (cohort A) or Flu/Cy (cohort B) and 1 × 108 CAR+ T cells per m2 after Flu/Cy (cohort C). The primary outcome was assessment of safety of one dose of HER2 CAR T cells after lymphodepletion.

  • Jul 19, 2023 | medium.com | Ahmed Salem

    One of the repos in the les-amateurs organization is kind of suspicious. Can you find all the real flags in that repository and report back? There are 3 flags total, one of which is worth 0 points.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →